Increased Gut Microbiota Diversity in Patients With Retinitis Pigmentosa and Implications for Disease Phenotypes and Progression

Key Points

• The study aims to explore the differences in gut microbiota between patients with retinitis pigmentosa and healthy individuals, and how these differences relate to disease progression.
• Compared gut microbiota of patients with retinitis pigmentosa and healthy individuals.
• Used a model mouse to assess the impact of antibiotic treatment on disease progression.
• Investigated potential therapeutic strategies targeting gut microbiota.
• Distinct gut microbiota profiles were identified in patients with retinitis pigmentosa compared to healthy individuals.
• Antibiotic treatment slowed disease progression in the retinitis pigmentosa model mouse.
• Targeting gut microbiota could be a potential strategy for managing retinitis pigmentosa.